These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
41 results:

  • 1. Does commission on cancer (CoC) accreditation mitigate the effect of care fragmentation on clinical outcome in localized rectal cancer?
    Park SS; Verm RA; Abdelsattar ZM; Kramer S; Swanson J; Fernando M; Cohn T; Luchette FA; Baker MS
    Am J Surg; 2024 Apr; 230():63-67. PubMed ID: 38148258
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Minimally invasive vs. open segmental resection of the splenic flexure for cancer: a nationwide study of the Italian Society of Surgical Oncology-colorectal cancer Network (SICO-CNN).
    Degiuli M; Ortenzi M; Tomatis M; Puca L; Cianflocca D; Rega D; Maroli A; Elmore U; Pecchini F; Milone M; La Mendola R; Soligo E; Deidda S; Spoletini D; Cassini D; Aprile A; Mineccia M; Nikaj H; Marchegiani F; Maiello F; Bombardini C; Zuolo M; Carlucci M; Ferraro L; Falato A; Biondi A; Persiani R; Marsanich P; Fusario D; Solaini L; Pollesel S; Rizzo G; Coco C; Di Leo A; Cavaliere D; Roviello F; Muratore A; D'Ugo D; Bianco F; Bianchi PP; De Nardi P; Rigamonti M; Anania G; Belluco C; Polastri R; Pucciarelli S; Gentilli S; Ferrero A; Scabini S; Baldazzi G; Carlini M; Restivo A; Testa S; Parini D; De Palma GD; Piccoli M; Rosati R; Spinelli A; Delrio P; Borghi F; Guerrieri M; Reddavid R
    Surg Endosc; 2023 Feb; 37(2):977-988. PubMed ID: 36085382
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prognostic implication of the neoadjuvant rectal score and other biomarkers of clinical outcome in Hong Kong Chinese patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiotherapy.
    Ho SSK; Hon SSF; Hung E; Lee JFY; Mo F; Tong M; So C; Chu S; Ng DCK; Lam D; Cho C; Mak TWC; Ng SSM; Futaba K; Suen J; To KF; Chan AWH; Yeung WWK; Ma BBY
    Hong Kong Med J; 2022 Jun; 28(3):230-238. PubMed ID: 35667869
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The prognostic significance of p63 cytoplasmic expression in colorectal cancer. An immunohistochemical study.
    Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS; Khalil AA
    Saudi Med J; 2019 May; 40(5):432-439. PubMed ID: 31056618
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of Plane of Total Mesorectal Excision With Prognosis of Rectal cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized clinical Trial.
    Kitz J; Fokas E; Beissbarth T; Ströbel P; Wittekind C; Hartmann A; Rüschoff J; Papadopoulos T; Rösler E; Ortloff-Kittredge P; Kania U; Schlitt H; Link KH; Bechstein W; Raab HR; Staib L; Germer CT; Liersch T; Sauer R; Rödel C; Ghadimi M; Hohenberger W;
    JAMA Surg; 2018 Aug; 153(8):e181607. PubMed ID: 29874375
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The outcome of Radiofrequency Ablation of Metastatic Liver Tumors.
    Thamtorawat S; Rojwatcharapibarn S; Tongdee T; Siriapisith T
    J Med Assoc Thai; 2016 Apr; 99(4):424-32. PubMed ID: 27396228
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Has the 'Fast-Track' referral system affected the route of presentation and/or clinical outcomes in patients with colorectal cancer?
    Thornton L; Reader H; Stojkovic S; Allgar V; Woodcock N
    World J Surg Oncol; 2016 Jun; 14(1):158. PubMed ID: 27278651
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. clinical outcome in patients treated with simultaneous integrated boost - intensity modulated radiation therapy (SIB-IMRT) with and without concurrent chemotherapy for squamous cell carcinoma of the anal canal.
    Tomasoa NB; Meulendijks D; Nijkamp J; Cats A; Dewit L
    Acta Oncol; 2016 Jun; 55(6):760-6. PubMed ID: 26878244
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
    Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
    Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Novel Immune Marker Model Predicts Oncological outcomes of Patients with colorectal cancer.
    Chen Y; Yuan R; Wu X; He X; Zeng Y; Fan X; Wang L; Wang J; Lan P; Wu X
    Ann Surg Oncol; 2016 Mar; 23(3):826-32. PubMed ID: 26581202
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Survival in Resected Stage II colorectal cancer Is Dependent on Tumor Depth, Vascular Invasion, Postoperative CEA Level, and The Number of Examined Lymph Nodes.
    Tsai HL; Huang CW; Chen CW; Yeh YS; Ma CJ; Wang JY
    World J Surg; 2016 Apr; 40(4):1002-9. PubMed ID: 26560149
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Management and clinical outcome in patients over 80 years with rectal cancer treated between 2006 and 2008 in Southern France (PACA region)].
    Moureau-Zabotto L; Gal J; Resbeut M; Mineur L; Teissier É; Hébuterne X; Muyldermans P; Francois É; Chamorey E; Gérard JP
    Cancer Radiother; 2015 Dec; 19(8):725-32. PubMed ID: 26548601
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BRAF codons 594 and 596 mutations identify a new molecular subtype of metastatic colorectal cancer at favorable prognosis.
    Cremolini C; Di Bartolomeo M; Amatu A; Antoniotti C; Moretto R; Berenato R; Perrone F; Tamborini E; Aprile G; Lonardi S; Sartore-Bianchi A; Fontanini G; Milione M; Lauricella C; Siena S; Falcone A; de Braud F; Loupakis F; Pietrantonio F
    Ann Oncol; 2015 Oct; 26(10):2092-7. PubMed ID: 26153495
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Contrast medium at the site of the anastomosis is crucial in detecting anastomotic leakage with CT imaging after colorectal surgery.
    Huiberts AA; Dijksman LM; Boer SA; Krul EJ; Peringa J; Donkervoort SC
    Int J Colorectal Dis; 2015 Jun; 30(6):843-8. PubMed ID: 25910890
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Therapeutic strategy for perforated colorectal cancer].
    Yoshikawa T; Akashi T; Hisano M; Asakura Y; Higashino N; Arimoto A; Hosono M; Ueno N; Ienaga T
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1725-7. PubMed ID: 25731309
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Shen L; Zhang H; Liang L; Li G; Fan M; Wu Y; Zhu J; Zhang Z
    Radiat Oncol; 2014 Dec; 9():295. PubMed ID: 25518933
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Coexistence of perineural invasion and lymph node metastases is a poor prognostic factor in patients with locally advanced rectal cancer after preoperative chemoradiotherapy followed by radical resection and adjuvant chemotherapy.
    Huang CM; Huang CW; Huang MY; Lin CH; Chen CF; Yeh YS; Ma CJ; Huang CJ; Wang JY
    Med Princ Pract; 2014; 23(5):465-70. PubMed ID: 25012611
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Impact of cancer on the clinical outcome of Patients After Inferior Vena Cava Filter Placement: A Retrospective Cohort Study.
    Narayan A; Hong K; Streiff M; Shinohara R; Frangakis C; Coresh J; Kim HS
    Am J Clin Oncol; 2016 Jun; 39(3):294-301. PubMed ID: 24781342
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
    Sevčíková K; Ušáková V; Bartošová Z; Sabol M; Ondrušová M; Ondruš D; Spánik S
    Klin Onkol; 2014; 27(1):38-44. PubMed ID: 24635436
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.